FDA Adverse Event Malfunction Summary report: N

BD PLASTIPAK¿ - 3-PIECE SYRINGE

MDR report key: 14137477 · Received April 18, 2022

Report

Report Number
3003152976-2022-00152
Event Type
Malfunction
Date Received
April 18, 2022
Date of Event
March 25, 2022
Report Date
October 3, 2022
Manufacturer
BECTON DICKINSON, S.A.
Product Code
FMF
PMA / PMN Number
K182589
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

H6: INVESTIGATION SUMMARY NO PHOTOS OR PHYSICAL SAMPLES THAT DISPLAY THE REPORTED CONDITION WERE AVAILABLE FOR INVESTIGATION. A DEVICE HISTORY REVIEW WAS PERFORMED FOR THE REPORTED LOT 2201069, NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THIS ISSUE. TEN RETAINED SAMPLES OF LOT 2201069 WERE USED TO FOR ADDITIONAL EVALUATION. THE PRODUCT WAS VISUALLY INSPECTED, NO DEFECTS OR DAMAGE WAS NOTED ON ANY OF THE SAMPLES OR COMPONENTS, THE STOPPER WAS PROPERLY ASSEMBLED ON THE PLUNGER, AND IN ALL CASES NO LEAKAGE WAS OBSERVED. FINAL PRODUCTS IN THIS MANUFACTURING LINE, FOR THIS REFERENCE ARE SAMPLED AND THEY ARE SUBJECTED TO VISUAL AND FUNCTIONAL INSPECTIONS DURING THE DIFFERENT MANUFACTURING SUB-PROCESSES ACCORDING TO PROCEDURES, INCLUDING LEAKAGE TESTING. RESULTS WERE REVIEWED AND PRODUCT WAS VERIFIED TO MEET REQUIRED SPECIFICATIONS. BASED ON THE AVAILABLE INFORMATION WE ARE NOT ABLE TO DETERMINE A ROOT CAUSE AT THIS TIME. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL BE MONITORED BY OUR QUALITY TEAM FOR SIGNS OF EMERGING TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING A BD PLASTIPAK¿ - 3-PIECE SYRINGE, LEAKAGE PAST THE STOPPER WAS OBSERVED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS WHEN THE PREPARER PULLED THE PLUNGER TO DRAW IN THE OXALIPLATIN (CYTOTOXIC) SOLUTION THAT HE NOTICED AN ABNORMAL INGRESS OF AIR AND THAT THE OXALIPLATIN BEGAN TO FLOW DOWN THE PLUNGER.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING A BD PLASTIPAK¿ - 3-PIECE SYRINGE, LEAKAGE PAST THE STOPPER WAS OBSERVED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS WHEN THE PREPARER PULLED THE PLUNGER TO DRAW IN THE OXALIPLATIN (CYTOTOXIC) SOLUTION THAT HE NOTICED AN ABNORMAL INGRESS OF AIR AND THAT THE OXALIPLATIN BEGAN TO FLOW DOWN THE PLUNGER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2715955 BD PLASTIPAK¿ - 3-PIECE SYRINGE PISTON SYRINGE FMF BECTON DICKINSON, S.A. 2201069

Patients

Seq Age Sex Outcome Treatment
1 Unknown